New User? Click here to register

What is the status of pathologists in the context of a multidisciplinary tumor boards?

Text generated by AI based on an exclusive interview, revised and reviewed by

Dr Jean-Philippe MINART, Cannes, France

March 8, 2022

Other local treatment options: Non-surgical ablations.
15.15 I 15.30

Maan HACHIMI
Predictive Models for Treatment Response and Adverse Events
Joseph GLIGOROV
What are the options in HER2 postive breast cancer treatments are we moving to t-DXd in first line?
Hassan GHAZAL
oncologist, Dubai
Early Detection Strategies and Their Impact on Breast Cancer Outcomes
Dana HADDAD
En quoi les RCP ont-elles permis de faire évoluer la prise en charge du cancer du sein ?
Pr Marc SPIELMANN, Président d'Honneur du BCU
Dubai 2022 Breast Cancer Update

Leave a Comment cancel

You must be logged in to post a comment.